Note: All stated doses are μg. 
Study selection for primary analyses of outcomes of interest
Of the 97 studies identified by the systematic literature search, 36 were considered for inclusion in the four outcome analyses. The remaining 61 were excluded as follows:
 10 were excluded because the study duration was ≤8 weeks  1 was excluded because patients aged <12 years were included  18 were excluded because patients were not on ICS or ICS/LABA at randomisation  18 were excluded because patients were not uncontrolled/symptomatic at baseline  14 were excluded because at least one of the treatment arms comprised a flexible dosing regimen and/or a dose-ranging arm.
Change from baseline PEF  18 of the 36 studies were excluded, all because they did not report usable change from baseline morning PEF data averaged over the whole study period. 18 studies were therefore included in the PEF MTC (Figure 1a) .
Change from baseline FEV 1  8 of the 36 studies were excluded because they did not report usable FEV 1 data or did not report FEV 1 change from baseline. 28 studies were therefore included in the  6 studies were therefore included in the exacerbations MTC (Figure 1c ).
